Literature DB >> 12426291

Justifying video-assisted thoracic surgery for spontaneous hemopneumothorax.

Yi-Cheng Wu1, Ming-Shian Lu, Chi-Hsiao Yeh, Yun-Hen Liu, Ming-Ju Hsieh, Hung-I Lu, Hui-Ping Liu.   

Abstract

STUDY
OBJECTIVES: Video-assisted thoracic surgery (VATS) has gained a prominent role in routine thoracic surgery practice. This study discusses the clinical aspects and utility of VATS in spontaneous hemopneumothorax (SHP). PATIENTS: Of 363 spontaneous pneumothorax (SP) cases, 24 patients presented with SHP (6.6%). The clinical features, surgical indications, emergency VATS technique, and patient outcomes are discussed.
RESULTS: All 24 patients were male (mean age, 25.3 years). Eleven patients were in hypovolemic shock, and their hemoglobin levels ranged from 6.7 to 12.7 g/dL; therefore, they received fluid resuscitation and blood transfusion. The amount of blood drained through the chest tube varied from 200 to 3,500 mL. Emergency VATS revealed that 5 cases were simple hemothoraces and 19 cases were associated with pneumothorax. The cause of bleeding was identified by thoracoscopy, as from an aberrant vessel (n = 11), torn parietal pleura (n = 4), ruptured vascularized bullae (n = 2), and lung parenchyma (n = 1). Six patients had no evidence of an obvious bleeding site. Bullous lesions were at the apex of the upper lobe in 14 patients, and multiple lobar involvement was seen in 2 patients. All the bullae were resected with endoscopic stapler in eight patients and ligated with a homemade endoloop in eight patients. The mean operation time was 42 min. The mean chest tube removal time was 3.5 days after insertion, and mean postoperative stay was 4.5 days. There is no recurrence of SHP or SP during the follow-up period.
CONCLUSION: SHP complicated by severe bleeding presents a potentially grave emergency. VATS may be considered as feasible treatment for patients with SHP.

Entities:  

Mesh:

Year:  2002        PMID: 12426291     DOI: 10.1378/chest.122.5.1844

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

1.  Early video-assisted thoracic surgery for primary spontaneous hemopneumothorax.

Authors:  Yu-Tang Chang; Zen-Kong Dai; Eing-Long Kao; Hung-Yi Chuang; Yu-Jen Cheng; Shah-Hwa Chou; Meei-Feng Huang
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

Review 2.  Review: Diagnosis and treatment of primary spontaneous pneumothorax.

Authors:  Shi-ping Luh
Journal:  J Zhejiang Univ Sci B       Date:  2010-10       Impact factor: 3.066

3.  Idiopathic massive spontaneous hemothorax: adhesion disruption.

Authors:  Shyam Singh; Mukhand L Sharma; Reyaz A Lone; Mehmood A Wani; Zahur Hussain; Ishtiyaq Mir; Puja Vimesh
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

4.  Spontaneous hemopneumothorax: epidemiological details and clinical features.

Authors:  Takuya Onuki; Yukinobu Goto; Masami Kuramochi; Masaharu Inagaki; Yukio Sato
Journal:  Surg Today       Date:  2013-10-17       Impact factor: 2.549

Review 5.  Video-assisted thoracic surgery for pneumothorax: republication of a systematic review and a proposal by the guideline committee of the Japanese association for chest surgery 2014.

Authors:  Taichiro Goto; Yoshihisa Kadota; Takeshi Mori; Shin-ichi Yamashita; Hirotoshi Horio; Takeshi Nagayasu; Akinori Iwasaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-09-04

6.  Spontaneous haemopneumothorax.

Authors:  Katie Chong; Sheharyar A Qureshi; Gabriela Badea; She Lok
Journal:  BMJ Case Rep       Date:  2011-08-19

7.  Spontaneous hemothorax during general anesthesia.

Authors:  Bijal R Parikh; Rouzbeh J Sattari; Nazly M Shariati; Robert S Dorain
Journal:  J Anesth       Date:  2009-02-22       Impact factor: 2.078

8.  Multiple-site bleeding at pleural adhesions and massive hemothorax following percutaneous coronary intervention with stent implantation: A case report.

Authors:  Xiaoli Luo; Weibin Shi; Xiaoqun Zhang; Xiaoli Yang; Wei Wang; Chunyu Zeng; Hongyong Wang
Journal:  Exp Ther Med       Date:  2018-01-02       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.